| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 01/18/2007 | US20070015802 Inhibitors of cyclin dependent kinases and their use |
| 01/18/2007 | US20070015801 Bactericides; (5R)-(-)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxamide |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070015753 crystallization of linezolid antibacterial agent in solvent and antisolvent |
| 01/18/2007 | US20070015752 Biaryl compositions and methods for modulating a kinase cascade |
| 01/18/2007 | US20070015743 Quinazoline derivatives as antitumor agents |
| 01/18/2007 | CA2615055A1 Ppar [alpha/gamma] agonists and processes of preparing |
| 01/18/2007 | CA2614726A1 New pyridine analogues |
| 01/18/2007 | CA2614691A1 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | CA2614544A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2612765A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1742942A1 Phenylthioacetic acid derivatives and use thereof |
| 01/17/2007 | EP1742935A1 Polycyclic pyrazines as potassium ion channel modulators |
| 01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/17/2007 | EP1742912A1 Novel androgens |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
| 01/17/2007 | CN1898238A Oxazolidinone-quinolone hybrid antibiotics |
| 01/17/2007 | CN1898235A Heterocyclic derivatives as gpcr receptor agonists |
| 01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/17/2007 | CN1898231A Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/17/2007 | CN1898217A Benzo'1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898206A Allosteric modulators of metabotropic glutamate receptors |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 01/17/2007 | CN1897931A Inhibitors of cathepsin s |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1896074A Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 01/17/2007 | CN1295223C Intermediate for preparing taxanes derivative |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/16/2007 | US7164026 Excellent as a ligand to be used in asymmetric synthesis reactions |
| 01/16/2007 | US7163953 Benzylether derivatives |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163949 for the treatment of various neurological and psychological disorders; compounds which block reuptake of norephinephrine, dopamine, and serotonin with particular selectivity ratios; reduced side effect profile |
| 01/16/2007 | US7163944 Cyclic diamine compound and pharmaceutical containing the same |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/16/2007 | CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 01/16/2007 | CA2212893C Prokinetic oxadiazoles |
| 01/11/2007 | WO2007005673A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | WO2007005000A1 Method of synthesis of imidazole-amino acid derivatives and related compounds |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004049A1 Oxazolidinones containing azetidine as antibacterial agents |
| 01/11/2007 | WO2007004037A1 Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2007003964A1 G-protein coupled receptor agonists |
| 01/11/2007 | WO2007003961A2 Gpcr agonists |
| 01/11/2007 | WO2007003960A1 Gpcr agonists |
| 01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 01/11/2007 | WO2007003077A1 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 01/11/2007 | WO2006124780A3 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
| 01/11/2007 | WO2006117211A3 Urea derivatives methods for their manufacture and uses thereof |
| 01/11/2007 | WO2006116007A3 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
| 01/11/2007 | WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 01/11/2007 | WO2006032342A3 Carbonyl compound-containing drug and the use thereof |
| 01/11/2007 | WO2006014359A3 Compounds useful for inhibiting chk1 |
| 01/11/2007 | WO2006009734A8 Gonadotropin releasing hormone receptor antagonists |
| 01/11/2007 | WO2005116023A8 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010668 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 01/11/2007 | US20070010556 Thiophene derivatives as chk 1 inhibitors |
| 01/11/2007 | US20070010551 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 01/11/2007 | US20070010534 Novel compounds |
| 01/11/2007 | US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/11/2007 | US20070010531 Substituted pyrazole compounds |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/11/2007 | US20070010516 Novel piperidine derivatives |
| 01/11/2007 | US20070010511 Organic compounds |
| 01/11/2007 | US20070010509 Cycloamine ccr5 receptor antagonists |
| 01/11/2007 | US20070009960 Characterising polypeptides |
| 01/11/2007 | DE102004040736B4 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614148A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | CA2614116A1 Histamine h3 receptor antagonists |
| 01/11/2007 | CA2614105A1 Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| 01/11/2007 | CA2613962A1 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 01/11/2007 | CA2613236A1 G-protein coupled receptor agonists |
| 01/11/2007 | CA2613235A1 Gpcr agonists |
| 01/11/2007 | CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/10/2007 | EP1741715A1 Epothilone derivatives and their synthesis and use |
| 01/10/2007 | EP1741714A1 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1740583A1 Oxadiazolone derivatives as ppar delta agonists |
| 01/10/2007 | EP1740581A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer"s disease |
| 01/10/2007 | EP1740579A1 Tricyclic pyrazole kinase inhibitors |